Applied dna awarded pooled surveillance testing contract valued at up to $2.0 million from suffolk county (n.y.) government

Stony brook, n.y.--(business wire)---- $apdn #covid19--applied dna sciences, inc. (nasdaq: apdn) (“applied dna” or the "company"), a leader in polymerase chain reaction (pcr)-based dna manufacturing, today announced that its wholly-owned subsidiary, applied dna clinical laboratories, llc (adcl), has secured a safecircle™ pooled covid-19 surveillance testing program (the “program”) award with a potential value of up to $2.0 million from the suffolk county (n.y.) government (the “county”). the 6-month term and awar
APDN Ratings Summary
APDN Quant Ranking